Optum: Why COVID-19 could significantly change the drug development pipeline
FierceHealthIT
DECEMBER 11, 2020
Optum: Why COVID-19 could significantly change the drug development pipeline. Fri, 12/11/2020 - 12:12.
135 
Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development
Digital Health Global
JANUARY 26, 2024
Under the program, Deliberate AI’s assessment tool for anxiety and depression, the AI-generated Clinical Outcome Assessment or AI-COA , will receive support to become a qualified drug development tool (DDT). Global experts have also expressed support for Deliberate AI’s innovative approach.
Join 82,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
6 challenges healthtech can help us tackle – Pt.2
Digital Health Global
NOVEMBER 2, 2023
Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates. There are three main advantages to the use of AI in drug development: width of research, speed of execution, low costs. DiMasi, H.G.
Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?
Lloyd Price
JUNE 17, 2023
When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. Background to the Teladoc Livongo merger The Teladoc Livongo merger was announced on August 5, 2020. The deal was completed on October 30, 2020. October 30, 2020: The merger is completed.
Bonus Features – August 7, 2022 – Patients like digital health but have security concerns, healthcare leaders optimistic “seamless” care is coming, and more
Healthcare IT Today
AUGUST 7, 2022
Cybersecurity company Surfshark found the number of government requests for user data increased 4x from 2013 to 2020 among Apple, Google, Facebook, and Microsoft. While 7 out of 10,000 may not seem like a lot, a large hospital with up to 20 connected devices per patient room could have several devices at risk.
Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future
Lloyd Price
DECEMBER 11, 2023
2020), leaving little doubt that virtual health and digital platforms will transform healthcare in the coming years.’ Digital health companies can help identify new drug targets, design clinical trials and analyse data more effectively. Some of the recent deals underscore the importance of virtual care in the pharmaceutical industry.’
Metformin Myths and Misconceptions
DrKumo Remote Patient Monitoring
APRIL 12, 2022
Though the drug metformin (a biguanide formed by the fusion of two guanidines) was developed in 1922 by Wermer and Bell, it was the efforts of the French physician Jean Sterne that paved the way for the use of metformin as a glucose-lowering drug. Updated 2020 Jan 21]. Griffin, S.J., Leaver, J.K. & & Irving, G.J.
Let's personalize your content